Literature DB >> 17016217

Acetabular revision with the Contour antiprotrusio cage: 2- to 5-year followup.

Mathias P Bostrom1, Andrew P Lehman, Robert L Buly, Stephen Lyman, Bryan J Nestor.   

Abstract

The Contour cage introduced in 1999 was designed to improve fixation and provide a surface for bone ongrowth. To determine whether the rates of radiographic loosening and/or revision have been reduced with the Contour design, we retrospectively reviewed the medical records and radiographs of 29 patients (average age, 68.1 years) undergoing 31 acetabular revisions with a Contour cage. The minimum followup was 24 months (mean 30 months, range, 24-58 months). Based on the Paprosky classification, two hips were Type 2B, seven were Type 3A, and 22 were Type 3B. Two hips (7%) were revised for loosening; one of these two was also infected. An additional five hips (16%) had signs of radiographic loosening. The mean Harris hip score improved from 45 to 80; functional scores improved less than the pain scores. Only 14 hips (45%) had an excellent or good clinical result and three of these 14 hips had radiographic signs of loosening; presuming these three hips eventually fail, only 35% of the hips had a good or excellent result. We found an association between number of previous surgeries and radiographic loosening and revision. Our data suggest the Contour cage offers little advantage over other antiprotrusio cages and highlight the substantial limitations of current methods available for treating patients with extensive acetabular bone loss.

Entities:  

Mesh:

Year:  2006        PMID: 17016217     DOI: 10.1097/01.blo.0000246533.37006.b0

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  10 in total

1.  A review of the treatment of pelvic discontinuity.

Authors:  M Villanueva; A Rios-Luna; J Pereiro De Lamo; H Fahandez-Saddi; M P G Böstrom
Journal:  HSS J       Date:  2008-07-15

Review 2.  The evolution of outcomes and indications for the dual-mobility cup: a systematic review.

Authors:  Cécile Batailler; Camdon Fary; Régis Verdier; Thierry Aslanian; Jacques Caton; Sebastien Lustig
Journal:  Int Orthop       Date:  2016-12-21       Impact factor: 3.075

3.  Treatment of large acetabular defects: a surgical technique utilizing impaction grafting into a metallic mesh.

Authors:  Johannes Buckup; Emiliano Alvarez Salinas; Alejandro Gonzalez Della Valle; Friedrich Boettner
Journal:  HSS J       Date:  2013-08-15

4.  Does a cemented cage improve revision THA for severe acetabular defects?

Authors:  Erik Hansen; David Shearer; Michael D Ries
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

5.  Acetabular Reconstruction in Total Hip Arthroplasty.

Authors:  Won Yong Shon; Siva Swaminathan Santhanam; Jung Woo Choi
Journal:  Hip Pelvis       Date:  2016-03-31

6.  Effects of Titanium Mesh Surfaces-Coated with Hydroxyapatite/β-Tricalcium Phosphate Nanotubes on Acetabular Bone Defects in Rabbits.

Authors:  Thuy-Duong Thi Nguyen; Tae-Sung Bae; Dae-Hyeok Yang; Myung-Sik Park; Sun-Jung Yoon
Journal:  Int J Mol Sci       Date:  2017-07-07       Impact factor: 5.923

7.  Acetabular revisions using porous tantalum components: A retrospective study with 5-10 years follow-up.

Authors:  Francesco Roberto Evola; Luciano Costarella; Giuseppe Evola; Martina Barchitta; Antonella Agodi; Giuseppe Sessa
Journal:  World J Orthop       Date:  2017-07-18

8.  Acetabular Cup Revision.

Authors:  Young-Ho Kim
Journal:  Hip Pelvis       Date:  2017-09-06

9.  Multicup reconstruction technique for the management of severe protrusio acetabular defects.

Authors:  Baochao Ji; Guoqing Li; Xiaogang Zhang; Yang Wang; Wenbo Mu; Li Cao
Journal:  Arthroplasty       Date:  2021-07-06

10.  Acetabular reconstruction with the Burch-Schneider antiprotrusio cage and bulk allografts: minimum 10-year follow-up results.

Authors:  Dario Regis; Andrea Sandri; Ingrid Bonetti
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.